April 07, 2015
On March 13, 2015, Governor Daugaard signed Senate Bill 101 into law. SB 101 prohibits plans that provide coverage for injected or intravenously administered cancer treatment medications from providing less favorable coverage for prescribed orally administered cancer treatment medications. Further, plans may not reclassify cancer treatment medications or increase copayments, deductibles, or coinsurance for medications that are injected or intravenously administered unless the increase is applied to all other medical and pharmaceutical benefits or the increase is consistent with the carrier’s annual increases in the cost of health care. Any reclassification of benefits with respect to cancer treatment medications must also be consistent with this legislation. SB 101 is effective Jan. 1, 2016.
SB 101 »